<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Subarachnoid hemorrhage grading scales</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Subarachnoid hemorrhage grading scales</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Subarachnoid hemorrhage grading scales</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert J Singer, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christopher S Ogilvy, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Guy Rordorf, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">José Biller, MD, FACP, FAAN, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alejandro A Rabinstein, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard P Goddeau, Jr, DO, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 10, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Nontraumatic subarachnoid hemorrhage (SAH) is most commonly caused by ruptured saccular aneurysms. SAH is often a devastating event with substantial mortality and high morbidity among survivors. The appropriate therapy for SAH depends in part upon the severity of hemorrhage. Level of consciousness on admission, patient age, and the amount of blood on initial head computed tomography (CT) scan are the most important prognostic factors for SAH at presentation [<a href="#rid1">1</a>].</p><p>Several grading systems are used in practice to standardize the clinical classification of patients with SAH based upon the initial neurologic examination and the appearance of blood on the initial head CT. This topic will provide an overview of the more commonly used clinical and radiologic grading scales for SAH. Other aspects of aneurysmal SAH are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/90075.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Epidemiology, risk factors, and pathogenesis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1130.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">INDIVIDUAL GRADING SCALES</span><span class="headingEndMark"> — </span>An ideal SAH grading scale would provide the following capabilities [<a href="#rid2">2-4</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Guide management decisions that are influenced by the severity of SAH</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Provide prognosis for clinicians, patients, and family members</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assist practitioners in their ability to compare individual patients and groups of similar patients regarding studies that examine the impact of new treatments</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enable practitioners to detect and quantify changes in disease severity while following an individual patient</p><p></p><p>While a number of SAH grading scales have been proposed, none meets all of these requirements or is universally accepted [<a href="#rid4">4,5</a>]. Results for an individual patient may vary depending on the interval between symptom onset and assessment of the patient. Furthermore, there is a paucity of validation studies, and no prospective controlled comparison studies have been performed.</p><p class="headingAnchor" id="H3"><span class="h2">Glasgow Coma Scale</span><span class="headingEndMark"> — </span>The Glasgow Coma Scale (GCS)  (<a class="graphic graphic_table graphicRef81854" href="/d/graphic/81854.html" rel="external">table 1</a>) was devised in the early 1970s [<a href="#rid6">6</a>]. The GCS is not a true SAH grading scale, but is rather a standardized method for evaluating the level of consciousness in a number of neurologic conditions including SAH. The GCS assigns points based on three parameters of neurologic function:</p><p class="bulletIndent1"><span class="glyph">●</span>Eye opening (spontaneous = 4, response to verbal command = 3, response to pain = 2, no eye opening = 1)</p><p class="bulletIndent1"><span class="glyph">●</span>Best verbal response (oriented = 5, confused = 4, inappropriate words = 3, incomprehensible sounds = 2, no verbal response = 1)</p><p class="bulletIndent1"><span class="glyph">●</span>Best motor response (obeys commands = 6, localizing response to pain = 5, withdrawal response to pain = 4, flexion to pain = 3, extension to pain = 2, no motor response = 1)</p><p></p><p>In a prospective series of 765 patients with SAH, a higher GCS correlated with better outcome after aneurysm surgery [<a href="#rid7">7</a>]. However, a significant difference in outcome was observed only between patients with GCS scores of 15 and 14, while no significant differences were found between the remaining adjacent GCS scores.</p><p>The interobserver variability of the GCS for patients with SAH is moderate (kappa 0.46) [<a href="#rid8">8</a>].</p><p>The GCS has been incorporated into several additional SAH grading systems. (See <a class="local">'World Federation of Neurological Surgeons grading scale'</a> below and <a class="local">'Ogilvy and Carter grading system'</a> below.)</p><p>It should be recognized that sedating medications and intubation can confound interpretation of the clinical SAH scales, particularly the GCS and those that incorporate it, since such interventions will reduce the level of consciousness and impair verbal responses.</p><p class="headingAnchor" id="H4"><span class="h2">Hunt and Hess grading system</span><span class="headingEndMark"> — </span>The grading system proposed by Hunt and Hess in 1968  (<a class="graphic graphic_table graphicRef69179" href="/d/graphic/69179.html" rel="external">table 2</a>) [<a href="#rid9">9</a>] is one of the most widely used [<a href="#rid10">10</a>]. The scale was intended as an index of surgical risk. The initial clinical grade correlates with the severity of hemorrhage.</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 1: Asymptomatic or mild headache and slight nuchal rigidity</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 2: Moderate to severe headache, stiff neck, no neurologic deficit except cranial nerve palsy</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 3: Drowsy or confused, mild focal neurologic deficit</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 4: Stupor, moderate or severe hemiparesis</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 5: Deep coma, decerebrate posturing</p><p></p><p>The grade is advanced one level for the presence of serious systemic disease (eg, hypertension, diabetes, severe arteriosclerosis, chronic pulmonary disease) or vasospasm on angiography.</p><p>A subsequent modification proposed by Hunt and Kosnik added a grade 0 for unruptured aneurysms and a grade 1a for a fixed neurologic deficit without other signs of SAH [<a href="#rid11">11</a>].</p><p>Although the Hunt and Hess scale is easy to administer, the classifications are arbitrary, some of the terms are vague (eg, drowsy, stupor, and deep coma) and some patients may present with initial features that defy placement within a single grade [<a href="#rid4">4</a>]. As an example, a rare presentation of SAH may include severe headache (ie, grade 2), normal level of consciousness, and severe hemiparesis (ie, grade 4). In such cases, the clinician must subjectively decide which of the presenting features is most important for determining the grade.</p><p>A systematic review of SAH grading scales found conflicting data regarding the utility of the Hunt and Hess scale for prognosis [<a href="#rid4">4</a>]. </p><p>Furthermore, it is unclear if there are significant differences in outcome for adjacent Hunt and Hess grades.</p><p class="bulletIndent1"><span class="glyph">●</span>Some studies evaluating Hunt and Hess grades found significant differences in outcome for some adjacent grades and not others [<a href="#rid8">8,12</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of 230 patients with SAH found a significant difference in outcome for compressed but not adjacent Hunt and Hess grades; patients with grades 1 to 3 had better outcomes compared with those with grades 4 and 5 [<a href="#rid13">13</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another study of 405 patients with SAH found no significant difference for the risk of poor outcome or death between patients with Hunt and Hess grades 0 to 2 [<a href="#rid2">2</a>]. Furthermore, the risk was significantly different only when comparing patients with Hunt and Hess grade 3 to those with grade 0.</p><p></p><p>The interobserver variability for the Hunt and Hess scale is moderate (kappa 0.41 to 0.48) [<a href="#rid8">8,14,15</a>].</p><p class="headingAnchor" id="H5"><span class="h2">World Federation of Neurological Surgeons grading scale</span><span class="headingEndMark"> — </span>The grading system of the World Federation of Neurological Surgeons (WFNS)  (<a class="graphic graphic_table graphicRef65468" href="/d/graphic/65468.html" rel="external">table 3</a>) was proposed in 1988 [<a href="#rid16">16</a>]. It is based on the GCS score (see <a class="local">'Glasgow Coma Scale'</a> above) and the presence of motor deficits.</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 1: GCS score 15, no motor deficit</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 2: GCS score 13 to 14, no motor deficit</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 3: GCS score 13 to 14, with motor deficit</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 4: GCS score 7 to 12, with or without motor deficit</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 5: GCS score 3 to 6, with or without motor deficit</p><p></p><p>Unlike the Hunt and Hess scale, the WFNS scale uses objective terminology to assign grades [<a href="#rid4">4</a>]. However, it may be more complex to administer than the Hunt and Hess scale because it requires assessment of both motor function and GCS. One study of 50 patients with SAH found that the interobserver variability for the WFNS scale was moderate (kappa of 0.6) [<a href="#rid15">15</a>].</p><p>A systematic review of SAH grading scales found conflicting data regarding the prognostic power of the WFNS grades [<a href="#rid4">4</a>]; two studies showed a stepwise increase in the likelihood of poor outcome with increasing WFNS grade [<a href="#rid8">8,17</a>], while others did not find consistent significant differences in outcome between adjacent WFNS grades [<a href="#rid7">7,12,18</a>]. In a study assessing a series of 185 patients with SAH, the Hunt and Hess score correlated more strongly with outcome at six months than the GCS or World Federation of Neurological Surgeons Scale (WFNS) [<a href="#rid19">19</a>]. However, individual grades for all three scales demonstrated suboptimal sensitivity, specificity, and predictive value. In addition, nearly half of the patients with poor scale grades on admission had a good outcome.</p><p>The WFNS in conjunction with the Japan Neurosurgical Society proposed a modification to the scale such that the presence of motor deficit as outlined above is excluded. In two studies, this modified scale appeared to have better discriminatory value compared with the original WFNS scale, but broader validation studies are required [<a href="#rid20">20-22</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Fisher scale</span><span class="headingEndMark"> — </span>The Fisher scale  (<a class="graphic graphic_table graphicRef81122" href="/d/graphic/81122.html" rel="external">table 4</a>) was devised in 1980 as an index of vasospasm risk (but not clinical outcome) based upon the hemorrhage pattern seen on initial head CT scan [<a href="#rid23">23</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Group 1: No blood detected</p><p class="bulletIndent1"><span class="glyph">●</span>Group 2: Diffuse deposition or thin layer with all vertical layers of blood (in interhemispheric fissure, insular cistern, or ambient cistern) less than 1 mm thick</p><p class="bulletIndent1"><span class="glyph">●</span>Group 3: Localized clots and/or vertical layers of blood 1 mm or more in thickness</p><p class="bulletIndent1"><span class="glyph">●</span>Group 4: Intracerebral or intraventricular clots with diffuse or no subarachnoid blood</p><p></p><p>The Fisher scale was validated in a small prospective series of 41 patients with SAH [<a href="#rid24">24</a>]. The interobserver variability for the Fisher scale indicates excellent agreement between observers (kappa 0.90) [<a href="#rid2">2</a>].</p><p>The Fisher scale has also been incorporated into other SAH grading systems. (See <a class="local">'The VASOGRADE'</a> below and <a class="local">'Ogilvy and Carter grading system'</a> below.)</p><p class="headingAnchor" id="H7"><span class="h2">Modified Fisher scale</span><span class="headingEndMark"> — </span>Like the Fisher scale, the modified Fisher scale (also known as the Claassen grading system) proposed in 2001 is an index of the risk of delayed cerebral ischemia due to vasospasm after SAH  (<a class="graphic graphic_table graphicRef57558" href="/d/graphic/57558.html" rel="external">table 5</a>) [<a href="#rid25">25,26</a>]. It does not address clinical outcome. Unlike the Fisher scale, the modified Fisher scale takes into account the separate and additive risk of SAH and intraventricular hemorrhage (IVH).</p><p>Ten cisterns or fissures are evaluated for blood with the modified Fisher scale. These include the frontal interhemispheric fissure, the quadrigeminal cistern, the bilateral suprasellar and ambient cisterns, and the bilateral basal sylvian and lateral sylvian fissures. The scale is graded as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 0: No SAH or IVH</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 1: Minimal SAH and no IVH</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 2: Minimal SAH with bilateral IVH</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 3: Thick SAH (completely filling one or more cistern or fissure) without bilateral IVH</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 4: Thick SAH (completely filling one or more cistern or fissure) with bilateral IVH</p><p></p><p>The modified Fisher scale was derived from analysis of data from 276 patients with SAH who had a head computed tomography (CT) scan within 72 hours of onset [<a href="#rid25">25</a>]. The best predictors of delayed cerebral ischemia due to vasospasm were thick SAH completely filling any cistern or fissure (odds ratio [OR] 2.3, 95% CI 1.5-9.5) and bilateral IVH (OR 4.1, 95% CI 1.7-9.8).</p><p>Interrater reliability has been reported to be suboptimal [<a href="#rid27">27</a>]. While the modified Fisher scale has been validated in retrospectively, prospective validation is awaited [<a href="#rid28">28,29</a>]. </p><p class="headingAnchor" id="H3360687589"><span class="h2">The VASOGRADE</span><span class="headingEndMark"> — </span>The VASOGRADE grading scale was developed to predict the risk of delayed cerebral ischemia following SAH [<a href="#rid30">30</a>]. It is based on the WFNS scale and modified Fisher scale (mFS) at time of admission. The scale is divided into three categories:</p><p class="bulletIndent1"><span class="glyph">●</span>Green – WFNS 1 or 2 and mFS 1 or 2</p><p class="bulletIndent1"><span class="glyph">●</span>Yellow – WFNS 1 to 3 and mFS 3 or 4</p><p class="bulletIndent1"><span class="glyph">●</span>Red – WFNS 4 or 5 and any mFS</p><p></p><p>Compared with patients classified as "green," patients classified as "red" had a higher risk for delayed cerebral ischemia (OR 3.19; 95% CI 2.07-4.50) [<a href="#rid30">30</a>]. Patients classified as "yellow" had a similar risk as those classified as "green" (OR 1.31; 95% CI 0.77-2.23).</p><p class="headingAnchor" id="H8"><span class="h2">Ogilvy and Carter grading system</span><span class="headingEndMark"> — </span>A SAH classification system to predict outcome for surgical management of SAH due to ruptured aneurysm was proposed by Ogilvy and Carter  (<a class="graphic graphic_table graphicRef70705" href="/d/graphic/70705.html" rel="external">table 6</a>) in 1998. It stratifies patients based upon age, Hunt and Hess grade (clinical condition), Fisher grade (SAH volume and vasospasm risk), and aneurysm size [<a href="#rid2">2</a>]. (See <a class="local">'Hunt and Hess grading system'</a> above and <a class="local">'Fisher scale'</a> above.)</p><p>One point is given for each of the following variables:</p><p class="bulletIndent1"><span class="glyph">●</span>Age greater than 50</p><p class="bulletIndent1"><span class="glyph">●</span>Hunt and Hess grade 4 to 5 (in coma)</p><p class="bulletIndent1"><span class="glyph">●</span>Fisher grade score 3 to 4</p><p class="bulletIndent1"><span class="glyph">●</span>Aneurysm size &gt;10 mm</p><p class="bulletIndent1"><span class="glyph">●</span>An additional point is added for a giant posterior circulation aneurysm (≥25 mm)</p><p></p><p>The total score ranges from 0 to 5, corresponding to grades 0 to 5.</p><p>The Ogilvy and Carter scale mitigates the potential subjectivity inherent in the Hunt and Hess system by compressing it into two grades (coma or no coma). Similarly, it compresses the Fisher scale into two grades. Nonetheless, it is more complex to administer than the Hunt and Hess scale, and requires knowledge of aneurysm size.</p><p>In a prospective evaluation of this system in 72 patients with SAH, the authors reported good to excellent outcomes in greater than 78 percent of patients with grades 0 to 2 [<a href="#rid2">2</a>]. In comparison, good outcomes were seen in 67 percent of grade 3 and 25 percent of grade 4 patients. Of note, there was no statistical difference in outcomes between grades 0 and 1. However, patients with grades 2, 3, and 4 had statistically worse outcomes compared with those in the adjacent lower grade. Only surgically treated patients were included in the study, and none with grade 5 had surgery.</p><p>The interobserver variability for the Ogilvy and Carter scale is very good, reflecting substantial observer agreement (kappa 0.69) [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H806830240"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/105370.html" rel="external">"Society guideline links: Stroke in adults"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Grading scale selection</strong> – Several subarachnoid hemorrhage (SAH) grading scales are available, but the selection of any grading scale is based on individual or institutional preference. No scale is optimal to help direct management, detect clinical changes over time, and guide prognosis. In addition, there are few validation studies of these scales and no prospective controlled comparison studies. (See <a class="local">'Individual grading scales'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Glasgow Coma Scale</strong> – The Glasgow Coma Scale (GCS)  (<a class="graphic graphic_table graphicRef81854" href="/d/graphic/81854.html" rel="external">table 1</a>) is a standardized scale for evaluating the level of consciousness. It is widely known and has utility for predicting outcome after SAH. Sedating medications and intubation can confound interpretation of the GCS. It has moderate interobserver variability. (See <a class="local">'Glasgow Coma Scale'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hunt and Hess grading scale</strong> – The Hunt and Hess grading scale  (<a class="graphic graphic_table graphicRef69179" href="/d/graphic/69179.html" rel="external">table 2</a>) assesses severity of SAH. It is widely used and is easy to administer, but the terminology is subjective and atypical presentations of SAH may be difficult to classify. The interobserver variability is moderate. (See <a class="local">'Hunt and Hess grading system'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>World Federation of Neurological Surgeons grading scale</strong> – The World Federation of Neurological Surgeons (WFNS) grading scale  (<a class="graphic graphic_table graphicRef65468" href="/d/graphic/65468.html" rel="external">table 3</a>) assesses severity of SAH. It uses the GCS score and objective terminology to assign grades. Interobserver variability for the WFNS scale is fair. (See <a class="local">'World Federation of Neurological Surgeons grading scale'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fisher and modified Fisher scales</strong> – The Fisher scale  (<a class="graphic graphic_table graphicRef81122" href="/d/graphic/81122.html" rel="external">table 4</a>) is an index of vasospasm risk (but not clinical outcome) based upon the hemorrhage pattern seen on initial head computed tomography (CT) scan. It has been validated prospectively, and interobserver variability is excellent. (See <a class="local">'Fisher scale'</a> above.)</p><p></p><p class="bulletIndent1">The modified Fisher scale  (<a class="graphic graphic_table graphicRef57558" href="/d/graphic/57558.html" rel="external">table 5</a>) is an index of the risk of delayed cerebral ischemia due to vasospasm after SAH. Unlike the Fisher scale, the modified Fisher scale takes into account the separate and additive risk of SAH and intraventricular hemorrhage (IVH). (See <a class="local">'Modified Fisher scale'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>VASOGRADE scale</strong> – The VASOGRADE is a three-category grading scale using the WFNS and modified Fisher scales to predict the risk of delayed cerebral ischemia following SAH. (See <a class="local">'The VASOGRADE'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ogilvy and Carter scale</strong> – The Ogilvy and Carter scale  (<a class="graphic graphic_table graphicRef70705" href="/d/graphic/70705.html" rel="external">table 6</a>) system was developed to predict outcome for surgical management of SAH due to ruptured aneurysm. It incorporates patient age, Hunt and Hess, Fisher grade, and aneurysm size. It is more complex to administer than Hunt and Hess. Interobserver variability for the Ogilvy and Carter scale is very good. (See <a class="local">'Ogilvy and Carter grading system'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hijdra A, van Gijn J, Nagelkerke NJ, et al. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke 1988; 19:1250.</a></li><li><a class="nounderline abstract_t">Ogilvy CS, Carter BS. A proposed comprehensive grading system to predict outcome for surgical management of intracranial aneurysms. Neurosurgery 1998; 42:959.</a></li><li><a class="nounderline abstract_t">Takagi K, Tamura A, Nakagomi T, et al. How should a subarachnoid hemorrhage grading scale be determined? A combinatorial approach based solely on the Glasgow Coma Scale. J Neurosurg 1999; 90:680.</a></li><li><a class="nounderline abstract_t">Rosen DS, Macdonald RL. Subarachnoid hemorrhage grading scales: a systematic review. Neurocrit Care 2005; 2:110.</a></li><li><a class="nounderline abstract_t">Dengler NF, Sommerfeld J, Diesing D, et al. Prediction of cerebral infarction and patient outcome in aneurysmal subarachnoid hemorrhage: comparison of new and established radiographic, clinical and combined scores. Eur J Neurol 2018; 25:111.</a></li><li><a class="nounderline abstract_t">Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2:81.</a></li><li><a class="nounderline abstract_t">Gotoh O, Tamura A, Yasui N, et al. Glasgow Coma Scale in the prediction of outcome after early aneurysm surgery. Neurosurgery 1996; 39:19.</a></li><li><a class="nounderline abstract_t">Oshiro EM, Walter KA, Piantadosi S, et al. A new subarachnoid hemorrhage grading system based on the Glasgow Coma Scale: a comparison with the Hunt and Hess and World Federation of Neurological Surgeons Scales in a clinical series. Neurosurgery 1997; 41:140.</a></li><li><a class="nounderline abstract_t">Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28:14.</a></li><li><a class="nounderline abstract_t">van Gijn J, Bromberg JE, Lindsay KW, et al. Definition of initial grading, specific events, and overall outcome in patients with aneurysmal subarachnoid hemorrhage. A survey. Stroke 1994; 25:1623.</a></li><li><a class="nounderline abstract_t">Hunt WE, Kosnik EJ. Timing and perioperative care in intracranial aneurysm surgery. Clin Neurosurg 1974; 21:79.</a></li><li><a class="nounderline abstract_t">Hirai S, Ono J, Yamaura A. Clinical grading and outcome after early surgery in aneurysmal subarachnoid hemorrhage. Neurosurgery 1996; 39:441.</a></li><li><a class="nounderline abstract_t">Proust F, Hannequin D, Langlois O, et al. Causes of morbidity and mortality after ruptured aneurysm surgery in a series of 230 patients. The importance of control angiography. Stroke 1995; 26:1553.</a></li><li><a class="nounderline abstract_t">Lindsay KW, Teasdale GM, Knill-Jones RP. Observer variability in assessing the clinical features of subarachnoid hemorrhage. J Neurosurg 1983; 58:57.</a></li><li><a class="nounderline abstract_t">Degen LA, Dorhout Mees SM, Algra A, Rinkel GJ. Interobserver variability of grading scales for aneurysmal subarachnoid hemorrhage. Stroke 2011; 42:1546.</a></li><li><a class="nounderline abstract_t">Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988; 68:985.</a></li><li><a class="nounderline abstract_t">Rosen DS, Macdonald RL. Grading of subarachnoid hemorrhage: modification of the world World Federation of Neurosurgical Societies scale on the basis of data for a large series of patients. Neurosurgery 2004; 54:566.</a></li><li><a class="nounderline abstract_t">Lagares A, Gómez PA, Lobato RD, et al. Prognostic factors on hospital admission after spontaneous subarachnoid haemorrhage. Acta Neurochir (Wien) 2001; 143:665.</a></li><li><a class="nounderline abstract_t">Aulmann C, Steudl WI, Feldmann U. [Validation of the prognostic accuracy of neurosurgical admission scales after rupture of cerebral aneurysms]. Zentralbl Neurochir 1998; 59:171.</a></li><li><a class="nounderline abstract_t">Sano H, Satoh A, Murayama Y, et al. Modified World Federation of Neurosurgical Societies subarachnoid hemorrhage grading system. World Neurosurg 2015; 83:801.</a></li><li><a class="nounderline abstract_t">Sano H, Inamasu J, Kato Y, et al. Modified world federation of neurosurgical societies subarachnoid hemorrhage grading system. Surg Neurol Int 2016; 7:S502.</a></li><li><a class="nounderline abstract_t">Fung C, Inglin F, Murek M, et al. Reconsidering the logic of World Federation of Neurosurgical Societies grading in patients with severe subarachnoid hemorrhage. J Neurosurg 2016; 124:299.</a></li><li><a class="nounderline abstract_t">Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6:1.</a></li><li><a class="nounderline abstract_t">Kistler JP, Crowell RM, Davis KR, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology 1983; 33:424.</a></li><li><a class="nounderline abstract_t">Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 2001; 32:2012.</a></li><li><a class="nounderline abstract_t">Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery 2006; 59:21.</a></li><li><a class="nounderline abstract_t">Melinosky C, Kincaid H, Claassen J, et al. The Modified Fisher Scale Lacks Interrater Reliability. Neurocrit Care 2021; 35:72.</a></li><li><a class="nounderline abstract_t">Kramer AH, Hehir M, Nathan B, et al. A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage. J Neurosurg 2008; 109:199.</a></li><li><a class="nounderline abstract_t">van der Steen WE, Leemans EL, van den Berg R, et al. Radiological scales predicting delayed cerebral ischemia in subarachnoid hemorrhage: systematic review and meta-analysis. Neuroradiology 2019; 61:247.</a></li><li><a class="nounderline abstract_t">de Oliveira Manoel AL, Jaja BN, Germans MR, et al. The VASOGRADE: A Simple Grading Scale for Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage. Stroke 2015; 46:1826.</a></li></ol></div><div id="topicVersionRevision">Topic 1094 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3176085" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9588539" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : A proposed comprehensive grading system to predict outcome for surgical management of intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10193613" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : How should a subarachnoid hemorrhage grading scale be determined? A combinatorial approach based solely on the Glasgow Coma Scale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16159052" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Subarachnoid hemorrhage grading scales: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28940973" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prediction of cerebral infarction and patient outcome in aneurysmal subarachnoid hemorrhage: comparison of new and established radiographic, clinical and combined scores.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4136544" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Assessment of coma and impaired consciousness. A practical scale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8805136" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Glasgow Coma Scale in the prediction of outcome after early aneurysm surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9218306" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A new subarachnoid hemorrhage grading system based on the Glasgow Coma Scale: a comparison with the Hunt and Hess and World Federation of Neurological Surgeons Scales in a clinical series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5635959" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Surgical risk as related to time of intervention in the repair of intracranial aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8042214" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Definition of initial grading, specific events, and overall outcome in patients with aneurysmal subarachnoid hemorrhage. A survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4608645" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Timing and perioperative care in intracranial aneurysm surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8875473" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical grading and outcome after early surgery in aneurysmal subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7660397" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Causes of morbidity and mortality after ruptured aneurysm surgery in a series of 230 patients. The importance of control angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6847910" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Observer variability in assessing the clinical features of subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21527761" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Interobserver variability of grading scales for aneurysmal subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3131498" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15028129" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Grading of subarachnoid hemorrhage: modification of the world World Federation of Neurosurgical Societies scale on the basis of data for a large series of patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11534686" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Prognostic factors on hospital admission after spontaneous subarachnoid haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9816668" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : [Validation of the prognostic accuracy of neurosurgical admission scales after rupture of cerebral aneurysms].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25535068" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Modified World Federation of Neurosurgical Societies subarachnoid hemorrhage grading system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27583174" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Modified world federation of neurosurgical societies subarachnoid hemorrhage grading system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26381248" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Reconsidering the logic of World Federation of Neurosurgical Societies grading in patients with severe subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7354892" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6682190" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11546890" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16823296" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33200331" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The Modified Fisher Scale Lacks Interrater Reliability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18671630" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30693409" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Radiological scales predicting delayed cerebral ischemia in subarachnoid hemorrhage: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25977276" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The VASOGRADE: A Simple Grading Scale for Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
